First Report on Association of Hyperuricemia with Type 2 Diabetes in a Vietnamese Population

Table 3

Association of elevated serum uric acid with hyperglycemia in multinomial logistic regression adjusted for confounding factors.

Model	IFG		IGT		IFG-IGT		Diabetes
	OR (95% CI)		OR (95% CI)		OR (95% CI)		OR (95% CI)
Total (n = 1542)
Model 1	2.58 (1.833.62)	<0.001	1.18 (0.75–1.85)	0.487	2.57 (1.48–4.48)	0.001	2.08 (1.48–2.92)	<0.001
Model 2	2.33 (1.63.3.32)	<0.001	1.15 (0.73–1.83)	0.544	2.50 (1.42–4.38)	0.001	1.96 (1.38–2.78)	<0.001
Model 3	2.31 (1.61–3.32)	<0.001	1.12 (0.71–1.79)	0.624	2.76 (1.55–4.90)	0.001	1.99 (1.39–2.83)	<0.001
Model 4	2.23 (1.54–3.23)	<0.001	1.08 (0.67–1.74)	0.744	2.29 (1.27–4.11)	0.006	1.75 (1.22–2.52)	0.002
Women (n = 1019)
Model 1	3.27 (2.17–4.93)	<0.001	1.14 (0.61–2.10)	0.685	4.43 (2.18–9.02)	<0.001	2.78 (1.81–4.28)	<0.001
Model 2	2.72 (1.77–4.19)	<0.001	1.14 (0.62–2.13)	0.672	3.91 (1.87–8.16)	<0.001	2.57 (1.65–4.02)	<0.001
Model 3	2.87 (1.84–4.50)	<0.001	1.21 (0.64–2.27)	0.559	4.44 (2.08–9.47)	<0.001	2.79 (1.76–4.41)	<0.001
Model 4	2.90 (1.83–4.58)	<0.001	1.07 (0.56–2.03)	0.837	3.96 (1.83–8.54)	<0.001	2.49 (1.55–3.99)	<0.001
Men (n = 523)
Model 1	1.57 (0.84–2.93)	0.154	1.14 (0.57–2.25)	0.717	1.05 (0.40–2.73)	0.924	1.26 (0.72–2.19)	0.421
Model 2	1.85 (0.96–3.55)	0.065	1.14 (0.57–2.28)	0.712	1.05 (0.40–2.79)	0.917	1.36 (0.77–2.41)	0.297
Model 3	1.72 (0.88–3.36)	0.114	1.06 (0.52–2.16)	0.879	1.10 (0.40–3.04)	0.859	1.36 (0.76–2.45)	0.304
Model 4	1.55 (0.78–3.08)	0.207	1.10 (0.53–2.29)	0.808	0.79 (0.27–2.29)	0.667	1.19 (0.65–2.19)	0.576

Model 1: unadjusted. Model 2: adjusted for socioeconomic status (age, gender, residence, marital status, education level, occupation, and income level). Model 3: Model 2 adjusted for lifestyle factors (consumption of wine and beer, smoking, consumption of sugary drinks, sporting habit, time spent for night’s sleep, siesta, watching television, and leisure sitting). Model 4: Model 3 adjusted for clinical patterns (body mass index, systolic blood pressure, diastolic blood pressure, and dyslipidemia). IFG, impaired fasting glucose; IGT, impaired glucose tolerance.